USCA RIA’s Kyntra Bio KYNB Stock Holding History

USCA RIA’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-533	Closed	-$617K	–	444
2018 Q4	$617K	Hold	533	–	–	0.08%	239
2018 Q3	$810K	Hold	533	–	–	0.08%	247
2018 Q2	$835K	Hold	533	–	–	0.09%	239
2018 Q1	$616K	Hold	533	–	–	0.07%	269
2017 Q4	$632K	Hold	533	–	–	0.07%	271
2017 Q3	$431K	Hold	533	–	–	0.06%	307
2017 Q2	$431K	Hold	533	–	–	0.06%	308
2017 Q1	$329K	Hold	533	–	–	0.05%	332
2016 Q4	$285K	Hold	533	–	–	0.04%	332
2016 Q3	$276K	Hold	533	–	–	0.05%	320
2016 Q2	$219K	Hold	533	–	–	0.04%	332
2016 Q1	$284K	Hold	533	–	–	0.05%	284
2015 Q4	$406K	Buy	+533	New	+$354K	0.09%	229

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

USCA RIA's KYNB Position: Q1 2019 in Review

USCA RIA sold out of Kyntra Bio (KYNB) in Q1 2019, closing a stake of 533 shares — an estimated $617K sold.

USCA RIA first reported a position in KYNB in Q4 2015 and held it in 13 quarters. The position peaked at $835K in Q2 2018. 225 funds tracked by Wall St. Rank hold KYNB as of Q1 2019.

USCA RIA reported no remaining Kyntra Bio position as of Q1 2019 after selling out during the quarter.
USCA RIA sold 533 Kyntra Bio shares in Q1 2019, an estimated $617K.
USCA RIA first reported a position in Kyntra Bio in Q4 2015 and held it in 13 quarters.
USCA RIA's Kyntra Bio position peaked at $835K in Q2 2018.
225 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2019.

Based on USCA RIA's 13F filing for Q1 2019, filed 13 May 2019.